ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Consolidation Unlikely to Save Money

December 17, 2010

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

GAO Report Refutes Charges Against Control Program

May 30, 1980

Nobel Physicist Calls For Doubling Of Science Budget

January 11, 1991